Ming Q Li

20120035702, Feb 9, 2012

Apr 23, 2010

13/265315

Keith Horvath - Washington DC, US
Dumitru Mazilu - Lutherville MD, US
Ming Li - Potomac MD, US

A61F 2/84
A61F 2/82

623 111, 623 116, 623 134, 623 146

An expandable stent () for use in the implantation of a valve prosthesis () using a delivery system () is disclosed. The self-expandable stent () includes a tubular lattice structure () defined by longitudinally aligned rods () connected to V- shaped struts () for forming a plurality of interconnected chevron-shaped six-sided polygons () that define a distal end zone () and a middle zone () of the tubular lattice structure (). A flare () or bend may be defined along opposite ends of each rod () to properly seat and prevent undue torsion of the stent () and valve prosthesis () during deployment and placement of the stent () within the lumen.

20230059264, Feb 23, 2023

Aug 18, 2022

17/890864

- College Park MD, US
- Durham NC, US
Jason Madjdi AMINI - Takoma Park MD, US
Kenneth WRIGHT - Berwyn Heights MD, US
Neal PISENTI - Laurel MD, US
Hermann UYS - Annapolis MD, US
Ming LI - Takoma Park MD, US
Michael Lurie GOLDMAN - Annapolis MD, US
Jeremy Matthew SAGE - Acton MA, US
Kai Makoto HUDEK - Hyattsville MD, US
Yunseong NAM - North Bethesda MD, US
Nikodem GRZESIAK - Morges, CH
Reinhold BLUMEL - Middletown CT, US

H01J 49/42
H01J 49/00

The use of multiple ion chains in a single ion trap for quantum information processing (QIP) systems is described. Each chain can have its own set of laser beams with which to implement and operate quantum gates within that chain, where each chain may therefore correspond to a single quantum computing register or core. Operations can be performed in parallel across all of these chains as they can be treated independently from each other. To implement and operate quantum gates between different chains, neighboring chains are merged into a single, larger chain, in which one can perform quantum gates between any of the ions in the larger chain. The combined chains can then be separated again by another shuttling event as needed. To implement and operate quantum gates between ions which do not occupy neighboring chains, swap gates can be used via a sequence of intervening chains.

20150150466, Jun 4, 2015

Apr 26, 2013

14/396064

- EINDHOVEN, NL
Ming Li - Potomac MD, US
Samuel Kadoury - Olney MD, US
Ankur Kapoor - Cranbury MD, US
Nicolaas Jan Noordhoek - Best, NL
Alessandro Guido Radaelli - Oirschot, NL
Bart Carelsen - Eindhoven, NL
Bradford Johns Wood - Bethesda MD, US

A61B 5/01
A61B 6/03
A61B 5/00
A61B 19/00
A61B 18/20
A61B 18/14
A61B 18/18
A61N 7/02
G06T 7/00
A61B 6/00

A computing device includes a thermal map generator ()that generates a thermal map for image data voxels or pixels representing a volume or region of interest of a subject based on thermometry image data, which includes voxels or pixels indicating a change in a temperature in the volume or region of interest, and a predetermined change in value to temperature lookup table () and a display () that visually presents the thermal map in connection with image data of the volume of interest. A method includes generating a thermal map for image data voxels or pixels representing a volume or region of interest of a subject based on thermometry image data, which includes voxels or pixels indicating a change in a temperature in the volume or region of interest, and a predetermined change in voxel or pixel value to temperature lookup table.

20140357554, Dec 4, 2014

May 12, 2014

14/275749

- Danbury CT, US
Robert Hauser - Columbia MD, US
Errol De Souza - Cambridge MA, US
Ming Li - Yorktown Heights NY, US
Bryan R. Wilson - Brewster NY, US

A61K 47/02
A61K 38/28

514 64

Compositions and methods for modulating injection site pain associated with rapid acting injectable insulin formulations have been developed for subcutaneous injection. The formulations contain insulin in combination with a zinc chelator such as ethylenediaminetetraacetic acid (“EDTA”), a dissolution/stabilization agent such as citric acid, a magnesium salt, and, optionally, additional excipients. New presentations include rapid acting concentrated insulin formulations and a way to enhance the absorption of commercially available rapid acting analog formulations by mixing them with a vial containing dry powder excipients that accelerate their absorption. Devices for mixing excipient and insulin together at the time of administration, while minimizing residence time of the mixture, are also described.

20140113856, Apr 24, 2014

Mar 14, 2013

13/826806

Biodel Inc - , US
Robert Hauser - Columbia MD, US
Ming Li - Yorktown Heights NY, US
Bryan R. Wilson - Brewster NY, US

A61K 47/02
A61K 38/28

514 64

Compositions and methods for modulating injection site pain associated with rapid acting injectable insulin formulations have been developed for subcutaneous injection. The formulations contain insulin in combination with a zinc chelator such as ethylenediaminetetraacetic acid (“EDTA”), a dissolution/stabilization agent such as citric acid, a magnesium salt, and, optionally, additional excipients. New presentations include rapid acting concentrated insulin formulations and a way to enhance the absorption of commercially available rapid acting analog formulations by mixing them with a vial containing dry powder excipients that accelerate their absorption. Devices for mixing excipient and insulin together at the time of administration, while minimizing residence time of the mixture, are also described.